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Treatments from Traditional Medicines
Although the promise of pharmacogenomics and the potential of
the human genome project have highlighted the possibility of
developing new drug targets, traditional medicines still provide a
rich source of potential medications. In this issue two papers study
traditional medicines and report biologic effects of their use. Dai
et al (p. 694) examine the effect of Juzen-taiho-to, a Japanese herbal
medicine, on the growth of primary melanocytic tumors in RET-
transgenic mice, and found that the rate of tumor growth in treated
mice was greatly suppressed during the entire period after initial
tumor development, with corresponding increased lifespan. The
mechanism appeared to be through the potentiation of T cell-
mediated antitumor cytotoxic immunity in vivo. The reagent is a
mixture of 10 kinds of herbs and therefore identi®cation of the
active ingredients is going to be a major phytopharmacologic
research project.
Miller et al (p. 612) studied an Amazonian herbal medicine,
Sangre de grado, a red tree sap, which has traditionally been used
for gastrointestinal distress and in¯ammation in addition to the
treatment of wounds and abrasions. The claims of reduced pain
in¯ammation and scarring were tested by examining the activation
of sensory afferent nerves in multiple animal models and in a clinical
trial, and there appeared to be suppression of activation of sensory
afferent nerves at a pre-junctional level, in addition to inhibition of
tissue responses to CGRP. This, then, is a further botanical with
measurable effect which warrants a detailed evaluation of its
therapeutic potential, and reminds us of our dependence on
information coming from observational studies, as well as the new
scienti®c methodology, to develop new treatments for skin
patients.
Circadian and Ultradian Rhythms of Skin Surface Properties
Circadian rhythms are physiologic changes occurring over time
with a reproducible waveform. We are generally familiar with them
in the context of well-being and other, perhaps so-called holistic,
aspects of our lives; however, it is increasingly evident that
circadian rhythms have important and clinically relevant application
to medicine and moreover, that they are underpinned by de®ned
molecular and cellular mechanisms. This is a rapidly emerging ®eld
of research and the role of circadian rhythms in applied skin
physiology is likely to become more important.
In this issue, in the paper by Le Fur et al (p. 718), facial and
forearm skin circadian rhythms were investigated in eight healthy
Caucasian women living under standardized conditions.
Noninvasive methods were used to assess a range of biophysical
properties over a 48 h period and were then subjected to statistical
analysis to identify periodicity. Circadian rhythms could be
detected for sebum secretion, transepidermal water loss, skin
temperature, pH, and capacitance.
This work con®rms the presence of measurable differences in
biophysical properties of the skin over time, and at different
anatomical sites. Whilst the results are dif®cult to compare with
previous studies due to differing experimental conditions, they
serve to highlight the need for standardized protocols for
chronobiologic studies on the skin. Moreover they provide a
rationale for examining possible therapeutic and other implications
of circadian rhythms in relation to topical drug pharmacology and
pharmacokinetics.
Skin Fibroblast Elastase and Photoageing
The molecular and cellular basis of photoageing is an expanding ®eld
of research, providing insights into the mechanisms of UV-induced
DNA damage and its repair, and generating potential targets for
therapeutic intervention. In this issue, in the paper by Tsukahara et al
(p. 671), the hypothesis is put forward that an increase in skin
®broblast elastase activity may be responsible for mediating the
increased tortuosity of dermal elastic ®bers and decrease in skin
elasticity that is associated with skin wrinkling following UV
exposure. To test the hypothesis, the skin of experimental rats was
irradiated with UVB three times a week for 6 weeks, together with
application of an increasing concentration of an inhibitor of skin
®broblast elastase to the same area. The authors were able to
demonstrate a concentration-dependent reduction in wrinkle
formation, together with maintenance of skin elasticity and dermal
®ber formation, with a peak effect at 1.0mMN-phenetylphosphonyl-
leucyl-tryptophane. Furthermore they found a signi®cant increase in
elastase activity in UVB-exposed, untreated rat skin compared with
areas that were UVB-exposed and treated. These data appear to
con®rm the role of skin ®broblast elastase in the degeneration and
tortuosity of dermal ®bers associated with UV-induced skin
wrinkling. They take us a step further towards a molecular
understanding of photoageing and the goal of eternal youth.
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Genomic Analysis of Basal Cell Carcinomas
Basal cell carcinoma (BCC) is the most common cancer in
Caucasians and, though they rarely metastasize, it can lead to
destruction of surrounding tissue. Previous genetic analysis of this
tumor type has revealed few regions of chromosomal loss or
ampli®cation; however, one common region of chromosomal loss
in BCC is 9q22.3 that occurs in 30%250% of tumors. The Patched
tumor suppressor gene was shown to be the target for this loss with
other components of the HedgehogPatched developmental signal-
ing pathway disrupted in a subset of other BCC.
Towards the identi®cation of other genes important in the onset
and progression of BCC, Ashton et al (p. 683) have applied the
technique of Comparative Genomic Hybridization (CGH) to
pinpoint common regions of chromosomal rearrangement. These
data con®rmed the conclusions of other studies using other
approaches, such as cytogenetics and loss of heterozygosity
(LOH), that BCC are relatively genetically stable in contrast to
other tumor types with few regions of chromosomal loss or
duplication. One striking observation, however, was the frequent
ampli®cation of the chromosomal region 6pter-p21 with almost
50% of tumors showing this speci®c chromosomal aberration.
Though this abnormality has been reported in previous studies, this
investigation strengthens the case for this region on chromosome 6
to harbor a major gene (or genes) involved in BCC development.
Further molecular studies will be required to ®ne map this
amplicon on chromosome 6pter-p21 in order to identify the target
gene. From preliminary database analysis of genes mapping in this
region, potential candidate genes could be the developmental genes
Notch4 or FREAC2, a member of the Forkhead gene family.
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